Imec (Leuven, Belgium), a leading research and innovation centre in nanoelectronics and digital technologies, announces a collaboration to develop a next-generation implantable device for peripheral nerve stimulation together with NeuroGyn AG, a Swiss medtech company specialised in neurostimulaton and surgical solutions for pelvic nerve disorders. Leveraging the expertise of imec The Netherlands at Holst Centre with respect to ultra-low power wireless communication and powering, the new solution aims at prolonging the lifetime of the device while lowering its cost, making it suitable at the point of need. Clinical validation is planned after the development phase.
The COVID-19 pandemic has highlighted the need for high-performance, resilient healthcare solutions worldwide. RFID technology contributes strongly to that by providing products for seamlessly tracking and tracing pharmaceutical items on a unit-of-use basis. DoseID, an industry consortium for the use of RFID technology in the healthcare and pharmaceutical space certifies RFID inlays for tracking of pharmaceuticals.
Identiv, Inc. (Fremont, California), a global leader in digital security and identification, recently joined the DoseID Consortium to strengthen its focus on radio frequency identification (RFID) applications in healthcare and participate in the development of industry standards for RFID use. DoseID connects industry participants from across the healthcare continuum to ensure RFID quality, performance, and interoperability for drug products and medical equipment. Identiv joins the consortium of leading healthcare companies sharing the mission and vision of DoseID to facilitate industry-wide collaboration for RFID healthcare standards.